Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 | 1.000 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.553 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.540 | |
| 1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.524 | |
| 1b39 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.519 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.511 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
| 4k2r | ANP | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.507 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.506 | |
| 4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.504 | |
| 1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
| 2ozo | ANP | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.501 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.496 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.496 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.496 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.494 | |
| 2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.492 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.491 | |
| 1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.488 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.487 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.487 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.486 | |
| 1day | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.483 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.483 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 5c03 | AGS | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.481 | |
| 1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
| 1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
| 2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
| 1ydt | IQB | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.478 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.478 | |
| 1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.477 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.477 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
| 4jrn | ANP | Rhoptry kinase family protein | / | 0.475 | |
| 4lrj | ANP | Uncharacterized protein | / | 0.475 | |
| 2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.473 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.472 | |
| 2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
| 1ict | T44 | Transthyretin | / | 0.469 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.469 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.468 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.467 | |
| 2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.466 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.466 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.465 | |
| 2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.464 | |
| 3orp | AGS | Serine/threonine protein kinase | / | 0.464 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.464 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
| 1ie4 | T44 | Transthyretin | / | 0.462 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.462 | |
| 3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.462 | |
| 4y12 | AGS | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.462 | |
| 2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.461 | |
| 3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.461 | |
| 3nie | ANP | Mitogen-activated protein kinase | / | 0.461 | |
| 3zon | IK1 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.461 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.461 | |
| 2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.460 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.460 | |
| 4pl4 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.460 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.460 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 2vnw | M01 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.459 | |
| 2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 1d7y | FAD | Ferredoxin reductase | / | 0.457 | |
| 1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.457 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 4wq5 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.456 | |
| 1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.455 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 3e8c | G96 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.455 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.455 | |
| 4crs | AGS | Serine/threonine-protein kinase N2 | 2.7.11.13 | 0.455 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.455 | |
| 1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 2uzw | SS4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
| 4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.453 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.452 | |
| 1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.452 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3ort | AGS | Serine/threonine protein kinase | / | 0.452 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 4iac | ACP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
| 1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.451 | |
| 3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 5j23 | A2R | Putative 2-hydroxyacid dehydrogenase | / | 0.451 | |
| 2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.450 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.450 | |
| 3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.450 | |
| 1o6k | ANP | RAC-beta serine/threonine-protein kinase | 2.7.11.1 | 0.449 | |
| 2cbs | R13 | Cellular retinoic acid-binding protein 2 | / | 0.449 | |
| 2vts | LZC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2w5a | ADP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.449 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
| 4rvo | ADP | Phenylacetate-coenzyme A ligase | / | 0.449 | |
| 3o7l | ANP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
| 3oog | YTP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 3x2u | ATP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
| 5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.448 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.447 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3hko | ANP | Calcium/calmodulin-dependent protein kinase with a kinase domain and 2 calmodulin-like EF hands | / | 0.446 | |
| 3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
| 4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3vn9 | ANK | Dual specificity mitogen-activated protein kinase kinase 6 | 2.7.12.2 | 0.445 | |
| 3ea0 | ATP | ATPase, ParA family | / | 0.444 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.444 | |
| 3keu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.444 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.444 | |
| 4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 2ojf | 4PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.443 | |
| 4fkl | CK2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.443 | |
| 1f8s | FAD | L-amino-acid oxidase | 1.4.3.2 | 0.442 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.442 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 3crl | ANP | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.442 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.441 | |
| 1vc2 | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.441 | |
| 2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3a5m | ATP | Major actin | / | 0.441 | |
| 3t80 | CTN | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 4.6.1.12 | 0.441 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.441 | |
| 4ekk | ANP | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.441 | |
| 4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.441 | |
| 4s26 | SAH | Phosphomethylpyrimidine synthase, chloroplastic | 4.1.99.17 | 0.441 | |
| 1ewy | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.440 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2f7e | 2EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3nbz | GTP | GTP-binding nuclear protein Ran | / | 0.440 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 |